FundedIQ
Biotechnology

Detact Diagnostics B.V.: Funding, Investors & Team (Oct 2026)

Detact holds the patent for a new, innovative, real-time, bacterial detection system that enables hospital staff to determine bacterial presence on surface areas with an easy to use system: the b-Swab.

www.detactdiagnostics.com LinkedIn Delfzijl, The Netherlands 1-10 employees
Biotechnology Health Care Health Diagnostics Therapeutics B2B
Total raised
$5.9M
Rounds
1
Latest
Undisclosed round
Nov 2025

Detact Diagnostics B.V. has raised $5.9M across 1 funding round on record, the most recent an undisclosed round of $5.9M announced in Nov 2025.

That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Detact Diagnostics B.V. Company Profile and Key Stats

Total funding raised
$5.9M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$5.9M in Nov 2025
Employees
1-10
reported band
Headquarters
Delfzijl, The Netherlands

Latest funding round on record: Nov 2025.

Detact Diagnostics B.V. Funding Rounds

Date
Round
Amount
Undisclosed round
$5.9M

Detact Diagnostics B.V. Founders and Leadership Team

Name
Role
Contact
Joost Gazendam
Founder
Locked

Contact details for the Detact Diagnostics B.V. team: 1 of 1 has an email address on file.

Start 14-day free trial →

Detact Diagnostics B.V. Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round

Detact Diagnostics B.V.'s latest round of $5.9M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Detact Diagnostics B.V. in Biotechnology and Delfzijl

Companies Similar to Detact Diagnostics B.V.

ProQR Therapeutics is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients…

Undisclosed round $59.2M

uniQure is a leader in the field of gene therapy and had developed the first and currently the only gene…

Undisclosed round $259M

Vertoro transforms woody and agricultural residues into a wide range of bio-based chemicals, materials, and…

Series B $11.5M

Vivici is a B2B ingredients firm that provides nutritious and sustainable animal-free dairy proteins…

Undisclosed round $11.5M

New Dawn Bio is a biotechnology research firm that specializes in wood production.

Pre-Seed $2.4M

Triple Bio is a biotech startup focused on improving productivity and sustainability in dairy and beef…

Pre-Seed $1.7M

Laigo Bio uses E3 ligase internalization to precisely degrade membrane proteins linked to autoimmune and…

Seed $6.4M

ATRO Medical is a spin-out from DSM and Radboudumc and builds on the knowledge developed in the…

Undisclosed round $3.5M
Series B $150M

BioLinker is a creation of manufactured science, protein blend packs, and protein.

Undisclosed round $1.7M

WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs…

Series B $26.0M

Tydra Labs is a biotechnology company that transforms crustacean shell waste into chitin and bio-products.

Seed $420k

Detact Diagnostics B.V. Funding FAQs

What does Detact Diagnostics B.V. do?

Detact holds the patent for a new, innovative, real-time, bacterial detection system that enables hospital staff to determine bacterial presence on surface areas with an easy to use system: the b-Swab.

How much funding has Detact Diagnostics B.V. raised?

Detact Diagnostics B.V. has raised $5.9M across 1 round on record. The most recent is an undisclosed round of $5.9M announced in Nov 2025.

When did Detact Diagnostics B.V. last raise funding?

Detact Diagnostics B.V.'s most recent funding round on record is an undisclosed round of $5.9M, announced in Nov 2025.

Who founded Detact Diagnostics B.V.?

FundedIQ lists Joost Gazendam (Founder) at Detact Diagnostics B.V..

Where is Detact Diagnostics B.V. headquartered?

Detact Diagnostics B.V. is based in Delfzijl, Groningen, The Netherlands.

How many employees does Detact Diagnostics B.V. have?

Detact Diagnostics B.V. is in the 1-10 employee band.

How does Detact Diagnostics B.V.'s funding compare to other Biotechnology startups?

Detact Diagnostics B.V.'s latest round of $5.9M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Detact Diagnostics B.V. Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Detact Diagnostics B.V. is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.